PUMA BIOTECHNOLOGY INC (PBYI) is a publicly traded Healthcare sector company. As of September 9, 2026, PBYI trades at $9.07 with a market cap of $484.71M and a P/E ratio of 14.66. PBYI moved -3.67% today. Year to date, PBYI is +52.10%; over the trailing twelve months it is +92.14%. Its 52-week range spans $2.58 to $9.74. Analyst consensus is neutral with an average price target of $6.00. Rallies surfaces PBYI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for PBYI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $9.07 |
| Market Cap | $484.71M |
| P/E Ratio | 14.66 |
| EPS | $0.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.74 |
| 52-Week Low | $2.58 |
| Volume | 389.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $228.37M |
| Net Income | $31.11M |
| Gross Margin | 74.53% |
1 analysts cover PBYI: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $6.00.